Despite promising functional data, previous genotype analyses could not confirm OPN as significant disease-modifying gene in classical Th17-mediated diseases such as multiple sclerosis [62], [63] and rheumatoid arthritis [64]. This evidence concerns the gene SPP1 and multiple sclerosis.